stars 1 stars 2 stars 3

Neursantys stands at the forefront of non-invasive bioelectronics, addressing neuromotor and neurocognitive conditions lacking widespread pharmacological solutions. Our flagship product platform, NEURVESTA, delivers the world’s first restorative neuroplastic treatment for age-related balance decline, a medical condition that is now known to begin as early as age 40 and affect over 70 million people in Canada and the U.S. alone.

Neursantys Questions

Neursantys is based in Menlo Park, California.

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users